Literature DB >> 17023124

Requirements for polyadenylation at the 3' end of LINE-1 elements.

Victoria P Belancio1, Megan Whelton, Prescott Deininger.   

Abstract

LINE-1 (L1) is the only active, autonomous, non-LTR, human retroelement. There are about 5x10(5) L1 copies in the human genome, the majority of which are truncated at their 5' ends. Both truncated and full-length L1 insertions contain a polyadenylation (polyA) signal at their 3' ends. A typical polyA site consists of the three main cis-acting elements: a conserved hexamer, cleavage site, and a GU-rich downstream region. A newly inserted L1 copy contains the conserved AATAAA hexamer at the end of its sequence. However, the GU-rich downstream region has to be provided by the neighboring genomic sequences and therefore it would vary for every L1 copy. Using northern blot analysis of transiently transfected L1 expression vectors we demonstrate that L1 element contain sequence that allow efficient polyadenylation at the L1 3' end upon retrotransposition into a new genomic location independent of the base composition downstream of the insertion site. The strategy of polyadenylation at the 3' end of L1 parallels the approach the element employs at its 5'UTR by having an unusual internal polymerase II promoter, making new insertions less dependent on the properties of the flanking sequences at the new locus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17023124     DOI: 10.1016/j.gene.2006.07.029

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  17 in total

1.  Characterization of L1-Ribonucleoprotein Particles.

Authors:  Martin S Taylor; John LaCava; Lixin Dai; Paolo Mita; Kathleen H Burns; Michael P Rout; Jef D Boeke
Journal:  Methods Mol Biol       Date:  2016

2.  Poly(A) binding protein C1 is essential for efficient L1 retrotransposition and affects L1 RNP formation.

Authors:  Lixin Dai; Martin S Taylor; Kathryn A O'Donnell; Jef D Boeke
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

3.  Affinity proteomics reveals human host factors implicated in discrete stages of LINE-1 retrotransposition.

Authors:  Martin S Taylor; John LaCava; Paolo Mita; Kelly R Molloy; Cheng Ran Lisa Huang; Donghui Li; Emily M Adney; Hua Jiang; Kathleen H Burns; Brian T Chait; Michael P Rout; Jef D Boeke; Lixin Dai
Journal:  Cell       Date:  2013-11-21       Impact factor: 41.582

4.  The impact of multiple splice sites in human L1 elements.

Authors:  V P Belancio; A M Roy-Engel; P Deininger
Journal:  Gene       Date:  2008-01-11       Impact factor: 3.688

Review 5.  Expressing genes do not forget their LINEs: transposable elements and gene expression.

Authors:  Kristine J Kines; Victoria P Belancio
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

6.  Characterization of a synthetic human LINE-1 retrotransposon ORFeus-Hs.

Authors:  Wenfeng An; Lixin Dai; Anna Maria Niewiadomska; Alper Yetil; Kathryn A O'Donnell; Jeffrey S Han; Jef D Boeke
Journal:  Mob DNA       Date:  2011-02-14

7.  Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition.

Authors:  Lixin Dai; Qing Huang; Jef D Boeke
Journal:  BMC Biochem       Date:  2011-05-05       Impact factor: 4.059

8.  A 3' Poly(A) Tract Is Required for LINE-1 Retrotransposition.

Authors:  Aurélien J Doucet; Jeremy E Wilusz; Tomoichiro Miyoshi; Ying Liu; John V Moran
Journal:  Mol Cell       Date:  2015-11-12       Impact factor: 17.970

9.  Distribution of the transposable elements bilbo and gypsy in original and colonizing populations of Drosophila subobscura.

Authors:  María Pilar García Guerreiro; Blanca E Chávez-Sandoval; Joan Balanyà; Lluís Serra; Antonio Fontdevila
Journal:  BMC Evol Biol       Date:  2008-08-14       Impact factor: 3.260

10.  Many LINE1 elements contribute to the transcriptome of human somatic cells.

Authors:  Sanjida H Rangwala; Lili Zhang; Haig H Kazazian
Journal:  Genome Biol       Date:  2009-09-22       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.